The New Zealand Ministry of Science has approved Argenta Global for a $4.7 million Technology Development Grant. The grant reimburses 20% of eligible R&D expenses, as much as $2.4 million per year.
“Argenta R&D transforms animal health innovations into commercially viable products,” said Doug Cleverly, Argenta founder and chief executive officer. “We also manufacture and ship those products to more than 40 countries on behalf of our customers. The Technology Development Grant helps ensure the continued success of our formulations R&D and analytical methods development program.”
Argenta supplies formulations and analytical methods R&D, as well as manufacturing for the global animal health industry.